Christopher T. Tallman
Henry Ford Health System, University of Michigan–Ann Arbor, Methodist Hospital
Papers
4
Total Citations
410
H-Index
4
About
Christopher T. Tallman is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for prostate and bladder cancers. His primary research areas include robot-assisted radical prostatectomy and cystectomy, with a focus on optimizing functional recovery, oncologic outcomes, and postoperative quality of life. Tallman’s most influential contribution is his landmark randomized controlled trial comparing Retzius-sparing versus standard robot-assisted radical prostatectomy, which demonstrated superior early urinary continence without compromising cancer control—a study that has garnered 176 citations and reshaped surgical practice. He has also conducted pivotal comparative effectiveness research, including a matched analysis (111 citations) and a comprehensive meta-analysis (81 citations) of robot-assisted versus open radical cystectomy, consistently showing reduced perioperative complications and improved recovery. Notably, his multi-institutional study using a validated bladder-specific instrument (42 citations) provided critical evidence on health-related quality of life after cystectomy. Through these high-impact studies, Tallman has established himself as a key figure in evidence-based urologic oncology, helping to define the modern standard of care for patients undergoing major pelvic cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Matched Comparison of Robotic-assisted and Open Radical Cystectomy111 citations · 2012
- 3
- 4